Today@Dal
» Go to news mainCMV Vaccine Study: Participants Needed
Researchers would like to develop a vaccine against CMV. The goal of a CMV vaccine would be to prevent CMV infection so that women would not pass the infection to their fetus. CMV infection of the developing fetus/baby be harmful, including causing hearing loss (deafness) and harming the brain's ability to develop. To date, there is no licensed vaccine against CMV.
Participants needed: Men and women between 18-40 years of age.
If you are interested in participating in this study, please contact Jill:
jill.mutch@iwk.nshealth.ca
470-3860
Recent News
- Buy your 50/50 tickets in support of United Way
- Temporary change to LMP entrances
- Call for 2025 OpenThinkers
- New surplus items added in Halifax and Truro
- Food services survey deadline extended
- In Memoriam: Dr. Herbert Hancock
- Newest OpenThink articles now available
- Where suppliers can meet Dal Procurement